Utah Medical Products (UTMD) Net Equity Issued and Repurchased (2010 - 2024)
Utah Medical Products (UTMD) posted quarterly Net Equity Issued and Repurchased of $294000.0 for Q2 2024, up 390.0% year-over-year from $60000.0 in Q3 2023, and up 206.25% quarter-over-quarter from $96000.0 in Q1 2024.
Utah Medical Products (UTMD) Net Equity Issued and Repurchased (2010 - 2024) Analysis & Trends
Utah Medical Products' Net Equity Issued and Repurchased history runs 15 years deep, the most recent figure standing at $294000.0 for Q2 2024.
- In Q2 2024, Net Equity Issued and Repurchased rose 390.0% year-over-year to $294000.0; the TTM figure through Mar 2025 stood at $294000.0 (up 53.12% YoY), while the FY2024 annual figure was $390000.0, up 233.33% from the prior year.
- Net Equity Issued and Repurchased for Q2 2024 stood at $294000.0, up from $96000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $294000.0 in Q2 2024, with the low at $3000.0 in Q2 2021.
- The 5-year median for Net Equity Issued and Repurchased is $60000.0 (2023), against an average of $94058.8.
- The sharpest annual moves came in 2021 and 2023: Net Equity Issued and Repurchased slumped 90.32% in 2021, then jumped 1400.0% in 2023.
- Utah Medical Products' Net Equity Issued and Repurchased stood at $76000.0 in 2020, then surged by 267.11% to $279000.0 in 2021, then plunged by 53.05% to $131000.0 in 2022, then slumped by 72.52% to $36000.0 in 2023, then surged by 716.67% to $294000.0 in 2024.
- Business Quant data shows UTMD's Net Equity Issued and Repurchased at $294000.0 in Q2 2024, $96000.0 in Q1 2024, and $36000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 29.31 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Utah Medical Products | 227.50 Mn | 139.97 Mn | 4.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 294,000.00 |
| Jun 30, 2024 | 294,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | 279,000.00 |
| Dec 31, 2021 | 279,000.00 |